Clinical Trials Logo

Blast Crisis clinical trials

View clinical trials related to Blast Crisis.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT00413270 No longer available - Clinical trials for Chronic Myelogenous Leukemia

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Start date: December 2006
Phase: Phase 3
Study type: Expanded Access

This study will evaluate the safety of nilotinib in adult patients with imatinib-resistant or -intolerant CML-blast crisis, CML-accelerated phase or CML-chronic phase when treated with nilotinib. Patients will be provided access to nilotinib until the drug is available on the market.